Grey matter damage in multiple sclerosis A pathology perspective

Prion

Volumn 7, Issue 1, 2013, Pages 66-75

  Klaver, Roel ^a   De Vries, Helga E ^a   Schenk, Geert J ^a   Geurts, Jeroen J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical relevance; Gray matter pathology; Imaging; Multiple sclerosis; Topology

Indexed keywords

ANTIINFLAMMATORY AGENT;

AUTOPSY; BRAIN ATROPHY; BRAIN DAMAGE; CONFERENCE PAPER; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; GRAY MATTER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; WESTERN BLOTTING;

CLINICAL RELEVANCE; GREY MATTER PATHOLOGY; IMAGING; MULTIPLE SCLEROSIS; TOPOLOGY;

ANIMALS; ATROPHY; CEREBRAL CORTEX; DEMYELINATING DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 84874593079     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.23499     Document Type: Conference Paper

References (73)

1. Lublin FD, Reingold SC; National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46:907-11; PMID:8780061; http://dx.doi.org/10.1212/WNL. 46.4.907.
2. Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006; 5:343-54; PMID:16545751; http://dx.doi.org/10.1016/S1474-4422(06) 70410-0.
3. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007; 6:903-12; PMID:17884680; http://dx.doi.org/10.1016/S1474-4422(07) 70243-0.
4. Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122:625- 39; PMID:10219776; http://dx.doi.org/ 10.1093/brain/122.4.625.
5. Bö L, Geurts JJG, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007; 64:76-80; PMID:17210812; http://dx.doi.org/10.1001/archneur.64.1.76.
6. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25:315-20; PMID:14016083; http://dx.doi.org/10.1136/jnnp.25.4.315.
7. Bø L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62:723-32; PMID:12901699.
8. Bø L, Vedeler CA, Nyland H, Trapp BD, Mørk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003; 9:323-31; PMID:12926836; http://dx.doi.org/10.1191/1352458503ms917oa.
9. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705-12; PMID:16230320; http://dx.doi.org/ 10.1093/brain/awh641.
10. Dutta R, Chang A, Doud MK, Kidd GJ, Ribaudo MV, Young EA, et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69:445-54; PMID:21446020; http://dx.doi.org/10.1002/ ana.22337.
11. Geurts JJG, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66:819-27; PMID:17805012; http://dx.doi.org/10.1097/nen. 0b013e3181461f54.
12. Gilmore CP, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol 2006; 16:202-8; PMID:16911477; http://dx.doi.org/10.1111/j.1750-3639.2006.00018.x.
13. Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009; 80:182- 7; PMID:18829630; http://dx.doi.org/10.1136/jnnp.2008.148767.
14. Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001; 60:1208-18; PMID:11764093.
15. Kooi EJ, Prins M, Bajic N, Beliën JAM, Gerritsen WH, van Horssen J, et al. Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol 2011; 122:313-22; PMID:21691765; http://dx.doi.org/10.1007/s00401- 011-0849-4.
16. Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007; 17:38-44; PMID:17493036; http://dx.doi.org/10. 1111/j.1750-3639.2006.00041.x.
17. Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009; 19:238-53; PMID:18492094; http://dx.doi.org/10.1111/j.1750- 3639.2008.00177.x.
18. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50:389-400; PMID:11558796; http://dx.doi.org/10.1002/ana.1123.
19. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64:1101- 7; PMID:16319720; http://dx.doi.org/10.1097/01.jnen.0000190067.20935.42.
20. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67:960-7; PMID:17000961; http://dx.doi.org/10.1212/01.wnl.0000237551.26858.39.
21. Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68:489- 502; PMID:19525897; http://dx.doi.org/10.1097/NEN.0b013e3181a19a5a.
22. Squire LR, Stark CEL, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004; 27:279-306; PMID:15217334; http://dx.doi.org/10.1146/annurev. neuro.27.070203.144130.
23. Moscovitch M, Nadel L, Winocur G, Gilboa A, Rosenbaum RS. The cognitive neuroscience of remote episodic, semantic and spatial memory. Curr Opin Neurobiol 2006; 16:179-90; PMID:16564688; http://dx.doi.org/10.1016/j.conb.2006. 03.013.
24. Bakshi R, Ariyaratana S, Benedict RH, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001; 58:742-8; PMID:11346369; http://dx.doi.org/10.1001/archneur.58.5.742.
25. Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17:1202-10; PMID:21561955; http://dx.doi.org/10. 1177/1352458511406575.
26. Geurts JJG, Pouwels PJW, Uitdehaag BMJ, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236:254-60; PMID:15987979; http://dx.doi.org/10.1148/radiol.2361040450.
27. Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJW, Wattjes MP, van der Valk P, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78:302-8; PMID:22218278; http://dx.doi.org/10.1212/WNL. 0b013e31824528a0.
28. Sethi V, Yousry TA, Muhlert N, Ron M, Golay X, Wheeler-Kingshott C, et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012; 83:877-82; PMID:22807559; http://dx.doi.org/10.1136/jnnp-2012-303023.
29. Nelson F, Poonawalla A, Hou P, Wolinsky JS, Narayana PA. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008; 14:1214-9; PMID:18952832; http://dx.doi.org/10.1177/1352458508094644.
30. Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen- Adad J, Mainero C. Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging 2012; 35:537- 42; PMID:22045554; http://dx.doi.org/10.1002/jmri.22847.
31. de Graaf WL, Kilsdonk ID, Lopez-Soriano A, Zwanenburg JJM, Visser F, Polman CH, et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol 2012; PMID:22898935.
32. Audoin B, Zaaraoui W, Reuter F, Rico A, Malikova I, Confort-Gouny S, et al. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry 2010; 81:690-5; PMID:20392976; http://dx.doi.org/10.1136/jnnp.2009.188748.
33. Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259:139-46; PMID:21720932; http://dx.doi.org/10.1007/s00415-011-6147-1.
34. Calabrese M, Rinaldi F, Mattisi I, Bernardi V, Favaretto A, Perini P, et al. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011; 77:257-63; PMID:21613600; http://dx.doi.org/10.1212/ WNL.0b013e318220abd4.
35. Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 2011; 17:1098-106; PMID:21586487; http://dx.doi.org/10.1177/1352458511404916.
36. Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64:1416-22; PMID:17923625; http://dx.doi.org/10.1001/archneur.64.10.1416.
37. Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 2009; 15:36-41; PMID:18755823; http://dx.doi.org/10.1177/1352458508096686.
38. Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009; 15:933-41; PMID:19667021; http://dx.doi.org/10.1177/1352458509106510.
39. Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010; 67:376-83; PMID:20373349.
40. Cohen-Adad J, Benner T, Greve D, Kinkel RP, Radding A, Fischl B, et al. In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 2011; 57:55-62; PMID:21511042; http://dx.doi.org/10.1016/j.neuroimage.2011.04.009.
41. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66:1144-50; PMID:19752305; http://dx.doi.org/10.1001/archneurol.2009.174.
42. Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009; 15:708-14; PMID:19435749; http://dx.doi.org/10. 1177/1352458509102907.
43. Roosendaal SD, Moraal B, Vrenken H, Castelijns JA, Pouwels PJW, Barkhof F, et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging 2008; 27:726-31; PMID:18302199; http://dx.doi.org/10.1002/ jmri.21294.
44. Geurts JJG, Bö L, Pouwels PJW, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26:572-7; PMID:15760868.
45. Nakamura K, Fisher E. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage 2009; 44:769-76; PMID:19007895; http://dx.doi.org/10.1016/j.neuroimage.2008.09. 059.
46. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64:255-65; PMID:18661561; http://dx.doi.org/10.1002/ana.21436.
47. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64:247-54; PMID:18570297; http://dx.doi.org/10.1002/ ana.21423.
48. Brink BP, Veerhuis R, Breij ECW, van der Valk P, Dijkstra CD, Bö L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005; 64:147-55; PMID:15751229.
49. van Horssen J, Brink BP, de Vries HE, van der Valk P, Bø L. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007; 66:321- 8; PMID:17413323; http://dx.doi.org/10.1097/nen. 0b013e318040b2de.
50. Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365:2188-97; PMID:22150037; http://dx.doi.org/10.1056/NEJMoa1100648.
51. Kooi EJ, Strijbis EM, van der Valk P, Geurts JJ. Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications. Neurology 2012; 79:1369-76; PMID:22972651; http://dx.doi.org/10.1212/WNL. 0b013e31826c1b1c.
52. Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 2012; 79:523-30; PMID:22764258; http://dx.doi.org/10.1212/ WNL.0b013e3182635645.
53. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308:1314- 8; PMID:15831717; http://dx.doi.org/10.1126/science.1110647.
54. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8:752-8; PMID:15895084; http://dx.doi.org/10.1038/nn1472.
55. Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 2003; 44:1-12; PMID:12951652; http://dx.doi.org/10.1002/glia.10276.
56. Nakanishi H. Microglial functions and proteases. Mol Neurobiol 2003; 27:163-76; PMID:12777686; http://dx.doi.org/10.1385/MN:27:2:163.
57. Taylor DL, Jones F, Kubota ESFCS, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial- derived Fas ligand. J Neurosci 2005; 25:2952- 64; PMID:15772355; http://dx.doi.org/10.1523/JNEUROSCI. 4456-04.2005.
58. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343:938-52; PMID:11006371; http://dx.doi.org/10. 1056/NEJM200009283431307.
59. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130:1089-104; PMID:17438020; http://dx.doi.org/10.1093/brain/awm038.
60. Torkildsen Ø, Stansberg C, Angelskår SM, Kooi EJ, Geurts JJG, van der Valk P, et al. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2010; 20:720- 9; PMID:19919606; http://dx.doi.org/10.1111/j.1750-3639.2009.00343.x.
61. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132:3318-28; PMID:19638446; http://dx.doi.org/10. 1093/brain/awp200.
62. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68:477-93; PMID:20976767; http://dx.doi.org/10.1002/ ana.22230.
63. Kooi EJ, Geurts JJG, van Horssen J, Bø L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol 2009; 68:1021- 8; PMID:19680141; http://dx.doi.org/10.1097/NEN.0b013e3181b4bf8f.
64. Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A 2004; 101:8168- 73; PMID:15148385; http://dx.doi.org/10.1073/pnas. 0402765101.
65. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006; 59:478-89; PMID:16392116 http://dx.doi.org/10.1002/ana.20736.
66. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177:95-103; PMID:10980305; http://dx.doi.org/10.1016/S0022-510X(00)00343-9.
67. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787-95; PMID:17051205; http://dx.doi.org/10.1038/nature05292.
68. Stys PK. Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies? Ann Neurol 2004; 55:601-3; PMID:15122698; http://dx.doi.org/10.1002/ana.20082.
69. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009; 8:280-91; PMID:19233038; http://dx.doi.org/10.1016/S1474-4422(09)70043-2.
70. Geurts JJG, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 2003; 126:1755-66; PMID:12805104; http://dx.doi.org/10.1093/brain/awg179.
71. Geurts JJG, Wolswijk G, Bö L, Redeker S, Ramkema M, Troost D, et al. Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. J Neuroimmunol 2005; 158:182-90; PMID:15589052; http://dx.doi.org/10.1016/j.jneuroim.2004.08.012.
72. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, et al. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 2008; 18:52-61; PMID:17924980; http://dx.doi.org/10.1111/j.1750-3639.2007.00101.x.
73. Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010; 133:858-67; PMID:20123726; http://dx.doi.org/ 10.1093/brain/awp335.